Global Neurology Radiopharma Product Leader

Define and execute the global neurology radiopharma product strategy with a primary focus on Parkinson’s and Alzheimer’s disease, integrating science, clinical development, regulatory, market access, and commercial perspectives to maximize asset value. Lead indication strategies, portfolio prioritization, and integrated evidence generation (IEGP) plans to drive adoption and demonstrate clinical and economic value across priority markets. Oversee lifecycle management from pre-launch to post-launch, identify opportunities for label expansion, and develop business cases for geographic expansion beyond the U.S. Collaborate across disciplines to align trial design, endpoints, and market access strategies, and build external credibility with neurology and neuroimaging communities. Candidates should have advanced degrees (e.g., PhD, MD, PharmD) with significant product leadership experience in neurology/radiopharmaceuticals, strong strategic and cross-functional execution capabilities, and a track record in launching diagnostic or imaging products in the U.S.